The GMP Cell Therapy Consumables Market Size is valued at 14.07 Mn in 2022 and is predicted to reach 139.19 Mn by the year 2031 at an 29.2% CAGR during the forecast period for 2023-2031.
Good Manufacturing Practices (GMP) ensure that products are manufactured and maintained under good quality standards. Cell therapy development processes are complex and require good pharmaceutical systems and quality control (QC).
The market growth is attributed to rising drug discovery, the high prevalence of cancer, cell therapy innovations, and the surging use of cell therapy & GMP cell therapy consumables. However, stringent regulatory policies may hamper the market growth. The increasing collaborations & partnership activities within companies operating in the GMP cell therapy consumables market for developing new products and cell therapy treatments also support the market growth. For instance, in March 2022, FUJIFILM Irvine Scientific, Inc. acquired Shenandoah Biotechnology, Inc., a leading manufacturer of recombinant proteins. Shenandoah Biotechnology recently launched their CTG Grade line of cytokines & growth factors manufactured according to cGMP guidelines in the company's new state-of-the-art, ISO 9001:2015 certified facility.
Moreover, the last five years have been a rebirth for cell therapy and gene therapy (CGT) innovation, and the COVID-19 pandemic has accelerated these developments.
Competitive Landscape:
Some of the Key Players in the GMP Cell Therapy Consumables Market:
- Sartorius AG
- Thermo Fisher Scientific Inc
- Miltenyi Biotec BV & Co KG
- Bio-Techne Corp
- Corning Inc
- FUJIFILM Irvine Scientific Inc
- Lonza Group AG
- BPS Bioscience Inc
- Merck KGaA
- Global Life Sciences Solutions USA LLC.
- Other Prominent Players
Market Segmentation:
The GMP Cell Therapy Consumables Market is segmented into Product, cell therapy, Process, and end user. By Product, the market is categorized into kits, reagents/molecular biology reagents, growth factors/cytokines and interleukins, and others. The cell therapy segment comprises NK cell therapy, stem cell therapy, T-cell therapy, and others. By Process, the market is divided into cell collection and characterization/sorting and separation, cryopreservationcell culture and expansion/preparation, cell processing and formulation, cell distribution/handling, cell isolation and activation, process monitoring and control/readministration/quality assurance, and others. The end user segment consists of clinical, commercial, and research.
By Product, The Kits Segment Held The Largest Market Share In 2022
The kits segment held the largest GMP cell therapy consumables market share in 2022. However, the growth factors/cytokines and interleukins segment is predicted to capture the highest CAGR over the forecast period.
By Cell Therapy, The T-Cell Therapy Segment Held The Largest Market Share
In 2022, the T-cell therapy segment held the largest share of the GMP cell therapy consumables market. Various clinical trials on Chimeric antigen receptor (CAR) T-cell therapy are being conducted for cancer treatment. The therapy improves the immune system's power, protecting against infections by destroying harmful viruses & bacteria. Such increasing clinical trials of CAR T-cell therapy are surging the demand for GMP cell therapy consumables.
By Process, The Cell Collection And Characterization/Sorting And Separation Segment Is Expected To Drive The GMP Cell Therapy Consumables Market
The cell collection, characterization/sorting, and separation segment are expected to drive the market during the forecast period. Moreover, the cryopreservation segment is anticipated to grow fastest in the coming years. Several companies in this market are building the GMP-compliant cell sorter to reduce contamination.
In Terms Of End Users, The Clinical Segment Dominates The Market
In 2022, the clinical segment led the GMP cell therapy consumables market. Increasing clinical trials due to the high prevalence of chronic diseases, rising clinical studies and research efforts for developing new cell therapies are expected to enhance the market growth over the projected period.
Regionally, North America Led The GMP Cell Therapy Consumables Market In 2022
Factors such as the increasing demand for cell therapies, the surging use of GMP cell therapy consumables, and rising research efforts in drug discoveries are responsible for the blooming of the GMP Cell Therapy Consumables Market in North America. At the same time, the Asia Pacific regional market is predicted to register the swiftest growth in the upcoming years. Growing cancer cases, chronic diseases, autoimmune disorders, and infectious diseases, increasing adoption of GMP cell therapy consumable products in India, and the development of cell therapy products are among the factors supporting the growth of the GMP Cell Therapy Consumables Market in this region.
GMP Cell Therapy Consumables Market Report Scope:
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 14.07 Bn |
|
Revenue Forecast In 2031 |
USD 139.19 Bn |
|
Growth Rate CAGR |
CAGR of 29.2 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product, By Cell Therapy, By Process, By End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Sartorius AG, Thermo Fisher Scientific Inc., Miltenyi Biotec BV & Co KG, Bio-Techne Corp, Corning Inc., FUJIFILM Irvine Scientific Inc., Lonza Group AG, BPS Bioscience Inc., Merck KGaA, Global Life Sciences Solutions USA LLC., and Others |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
